Acute profound thrombocytopenia following C7E3 FAB (abciximab) therapy.
Publication
, Journal Article
Berkowitz, SD; Harrington, RA; Rund, MM; Tcheng, JE
Published in: BLOOD
November 15, 1996
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 15, 1996
Volume
88
Issue
10
Start / End Page
2055 / 2055
Publisher
W B SAUNDERS CO
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Berkowitz, S. D., Harrington, R. A., Rund, M. M., & Tcheng, J. E. (1996). Acute profound thrombocytopenia following C7E3 FAB (abciximab) therapy. BLOOD, 88(10), 2055–2055.
Berkowitz, S. D., R. A. Harrington, M. M. Rund, and J. E. Tcheng. “Acute profound thrombocytopenia following C7E3 FAB (abciximab) therapy.” BLOOD 88, no. 10 (November 15, 1996): 2055–2055.
Berkowitz SD, Harrington RA, Rund MM, Tcheng JE. Acute profound thrombocytopenia following C7E3 FAB (abciximab) therapy. BLOOD. 1996 Nov 15;88(10):2055–2055.
Berkowitz, S. D., et al. “Acute profound thrombocytopenia following C7E3 FAB (abciximab) therapy.” BLOOD, vol. 88, no. 10, W B SAUNDERS CO, Nov. 1996, pp. 2055–2055.
Berkowitz SD, Harrington RA, Rund MM, Tcheng JE. Acute profound thrombocytopenia following C7E3 FAB (abciximab) therapy. BLOOD. W B SAUNDERS CO; 1996 Nov 15;88(10):2055–2055.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 15, 1996
Volume
88
Issue
10
Start / End Page
2055 / 2055
Publisher
W B SAUNDERS CO
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology